Flow cytometry plays an essential role in the diagnosis of acute myeloid leukemia (AML). It allows doctors to identify the specific types of blood and bone marrow cells that are abnormal, which is necessary for correctly diagnosing and classifying AML subtypes. This detailed analysis via flow cytometry is critical for determining appropriate treatment options and monitoring treatment responses in patients with AML.